The development of smart pumps has allowed easy access to homecare infusion procedures. Smart pumps are improving the overall scenario of use for the patients. In addition, increasing demand for reduction in the total stay time of patient owing to increasing hospital expenses has led to the introduction of infusion therapy pumps as an alternative in healthcare settings such as homecare, thus ensuing in overall market growth. Infusion pump is a medical equipment which delivers fluids including medications and nutrients to a patient’s body in limited and controlled amounts. Infusion pumps are being broadly utilized in clinical settings such as nursing homes, hospitals and homes. Generally, an infusion pump is functioned by a trained professional, who plans the duration and rate of fluid delivery using a built-in software edge. Infusion pumps provide considerable benefits over manual pumps which include the ability to deliver fluids in very small volumes, and the capability to deliver fluids at accurately automated intervals and programmed rates. Infusion pumps can easily deliver medications and nutrients such as hormones, insulin chemotherapy drugs, antibiotics and pain relieving drugs.

Some of the major drivers pertaining in the global infusion therapy pumps market include increasing geriatric population, increase in burden of diseases as well as the wide presence of highly unmet medical demands especially in the low income regions. Moreover, the increasing demand to minimize the overall healthcare costs has led to an increase in the inclination of consumers towards homecare therapies across patients, mainly the geriatric population which further require a long term care. Infusion pumps offer a large number of advantages when compared to manual fluid delivery systems due to their capability to manage the required fluid volumes at automated and pre programmed intervals. Furthermore, the widespread availability of infusion pumps offered by the key market players is anticipated to further boost the overall market demand. Also, with the increasing geriatric population, an increase in the incidence of several medical conditions necessitating prolonged care is expected in the near future. However, lack of skilled professionals is one of the key factors hampering the growth of the global infusion pumps market.

The global infusion therapy pumps market can be segmented on the basis of type, application and geography. On the basis of type, the global infusion therapy pumps market can be segmented into insulin pumps, ambulatory infusion pumps, elastomeric pumps, syringe pumps, and patient controlled analgesics. On the basis of application, the global infusion therapy pumps market can be segmented into endocrinology, anti-infective, hydration therapy, enteral nutrition, chemotherapy, specialty pharmaceuticals, parenteral nutrition, and others. On the basis of geography, the global infusion therapy pumps market can be segmented into North America, Europe, Asia Pacific and Rest of the World

Some of the key players in the global infusion pumps market include GE Healthcare, Koninklijke Philips N.V., Welch Allyn, Hill-rom Company, Inc., Schiller AG, Fukuda Denshi Co. Ltd., Nihon Kohden Corporation, Mortara Instrument, Inc. and Spacelabs Healthcare, Inc. among others.